Epigenetics in Cancer: Understanding the role of epigenetic changes in cancer progression.

Epigenetics is reshaping our understanding of cancer by exploring the heritable changes in gene expression that do not involve alterations in DNA sequences. Epigenetic modifications, such as DNA methylation, histone modifications, and non-coding RNAs, play a crucial role in regulating gene activity and cellular behavior. In cancer, these changes often silence tumor suppressor genes or activate oncogenes, driving tumorigenesis. Unlike genetic mutations, epigenetic alterations are potentially reversible, making them attractive targets for therapeutic intervention. Drugs like DNA methyltransferase inhibitors and histone deacetylase inhibitors have shown promise in reactivating silenced genes and restoring normal cellular functions. Epigenetics also holds potential in early cancer detection, as specific epigenetic patterns serve as biomarkers in liquid biopsies. By unraveling the complexities of the epigenetic landscape, researchers aim to develop innovative treatments and diagnostic tools that could transform cancer care.